COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Clinical trials for COMMUNITY-ACQUIRED PNEUMONIA (CAP) explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY-ACQUIRED PNEUMONIA (CAP) trials appear
Sign up with your email to follow new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Steroid showdown: hydrocortisone vs prednisolone for pneumonia
Disease control Recruiting nowThis study compares two common steroids, hydrocortisone and prednisolone, in adults hospitalized with severe community-acquired pneumonia. The main goal is to see if one reduces deaths within 30 days more than the other. About 1,600 participants will be randomly assigned to one o…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE4 • Sponsor: Copenhagen Respiratory Research • Aim: Disease control
Last updated May 26, 2026 03:43 UTC
-
New study tests 'Watch and Wait' antibiotic strategy for kids with pneumonia
Disease control Recruiting nowThis study looks at whether a 'watch and wait' approach to giving antibiotics can safely reduce unnecessary antibiotic use in children with mild pneumonia. About 2,000 children will be randomly assigned to either get antibiotics right away or wait 72 hours to see if they improve …
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated May 26, 2026 03:37 UTC
-
Pneumonia study aims to cut unnecessary antibiotic use in kids
Disease control Recruiting nowThis study looks at whether some children with mild pneumonia can recover without antibiotics. About 700 kids aged 6 months to 18 years who visit the emergency room with pneumonia but are well enough to go home will take part. Doctors will compare standard antibiotic treatment ag…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Jeffrey Pernica • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Pneumonia patients get heart drug in artery inflammation trial
Disease control Recruiting nowThis study tests if a drug called icosapent ethyl (Vascepa) can reduce inflammation in the arteries of adults hospitalized with community-acquired pneumonia. Inflammation from pneumonia can harm blood vessels, raising heart risks. Over 6 months, 168 participants will take either …
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New study tracks pneumonia in vulnerable patients
Knowledge-focused Recruiting nowThis study observes 1298 adults with weakened immune systems who are hospitalized for pneumonia. Researchers will track causes, treatments, and outcomes over one year. No new treatments are tested; the goal is to learn more about this condition to improve future care.
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Sponsor: Societa Italiana di Pneumologia • Aim: Knowledge-focused
Last updated May 26, 2026 03:44 UTC
-
New study aims to curb antibiotic overuse for coughs and colds
Knowledge-focused Recruiting nowThis study tests whether a two-part approach—helping doctors communicate about viral infections and having pharmacists check prescription lengths—can reduce how many days antibiotics are prescribed for common respiratory infections like bronchitis, sinusitis, and sore throat. Abo…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC